Arabic Arabic English English French French German German
dark

Shoreline Biosciences Appoints Vanessa L. Jacoby as Chief Financial Officer

 Shoreline Biosciences, Inc. (Shoreline), a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized and targeted natural killer (NK) and Macrophage cellular immunotherapies derived from induced pluripotent stem cells (iPSC) for cancer and other serious diseases, today announced the appointment of Vanessa L. Jacoby as Chief Financial Officer. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada

Next Post

The Australian TGA approves key label updates to Buvidal® for treatment of opioid dependence

Related Posts
Total
0
Share